IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Alkem Laboratories IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1349.61 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Axis Capital , Edelweiss Financial Services , J.P. Morgan India , Nomura Financial Advisory And Securities (India) are the merchant bankers of Alkem Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 6th August 2015.
Alkem Laboratories IPO posted revenues of ₹ 4,119.20 Cr. and PAT of ₹ 829.40 Cr. in FY16 on annualised basis.
Revenue:
₹ 4,119.20 Cr.
EBITDA Margin:
23.80
% 
Net Worth: ₹ 3468.60 Cr.
Market Capitalisation:
[●]
P/E:
28.00 times
P/BV: [●]
EV/EBITDA: 0.37 times
Financial results of Alkem Laboratories IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-15 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 5118.10 | 4866.30 | 4201.50 | 4011.20 | |
| Net Worth | 3468.60 | 3097.10 | 2714.90 | 2302.60 | |
| Total Debt | 872.20 | 1074.30 | 899.10 | 1185.90 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
2059.60
4,119.20 |
3182.90 | 2672.90 | 2300.90 | |
EBITDA
EBITDA on annualised basis |
490.20
980.40 |
593.70 | 563.10 | 597.10 | |
PAT
PAT on annualised basis |
414.70
829.40 |
438.80 | 440.20 | 466.70 | |
Alkem Laboratories IPO PAT Margin is 20.13 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Alkem Laboratories IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-15 | FY15 | FY14 | FY13 |
|---|---|---|---|---|
| EBITDA Margin (%) | 23.80 | 18.65 | 21.07 | 25.95 |
| PAT Margin (%) | 20.13 | 13.79 | 16.47 | 20.28 |
| EPS (₹) | 34.70 | 36.70 | 37.80 | 39.00 |
| ROE (%) | 11.96 | 14.17 | 16.21 | 20.27 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 8.10 | 9.02 | 10.48 | 11.63 |
| Debt to Equity | 0.25 | 0.35 | 0.33 | 0.52 |
The market Capitalisation of Alkem Laboratories IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Alkem Laboratories IPO prospectus highlights an Return on Equity (ROE) of 11.96 % , Return on Assets (ROA) of 8.10 %, and an EBITDA Margin of 23.80 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Alkem Laboratories IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Alkem Laboratories IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Alkem Laboratories IPO has a Price-to-Earnings (PE) ratio of 28.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Alkem Laboratories IPO reported revenue of ₹ 5318.00 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Alkem Laboratories IPO provide insights into sales growth, market demand, and business scalability.
Alkem Laboratories recorded an EBITDA of ₹ 980.40 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Alkem Laboratories Profit After Tax (PAT) is ₹ 829.40 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 4,119.20 Cr.
EBITDA Margin:
23.80
%
Net Worth: ₹ 3,468.60 Cr.
Market Capitalisation:
[●]
P/E:
28.00 times
P/BV: [●]
EV/EBITDA:
[●]
Alkem Laboratories operates in Pharmaceutical and Development Manufacture And Sale Of Pharmaceutical And Neutraceutical Products. The Issue is listed on BSE,NSE in Dec, 2015. Alkem Laboratories IPO size was 1349.61 with Issue price of 1050.00 .
Merchant Banker(s) of Alkem Laboratories IPO: Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited
Alkem Laboratories IPO subscription was 44.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Alkem Laboratories IPO listed at a listing price of 1381.45 against the offer price of 1050.00.
The current market price of Alkem Laboratories is 4998.50.
Why Us?
